Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells

International Journal of Colorectal Disease

Volumn 27, Issue 11, 2012, Pages 1401-1408

  Faltejskova, Petra ^a   Besse, Andrej ^a   Sevcikova, Sabina ^b   Kubiczkova, Lenka ^b   Svoboda, Marek ^a   Smarda, Jan ^b   Kiss, Igor ^a   Vyzula, Rostislav ^a   Slaby, Ondrej ^a,b  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

5 FU; Apoptosis; Colorectal cancer; DLD 1; L OHP; Migration; MiR 21; Sensitivity; SN38

Indexed keywords

FIRTECAN; FLUOROURACIL; MICRORNA 21; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STAGING; CELL CYCLE S PHASE; CELL VIABILITY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIGRATION INHIBITION; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED;

EID: 84867996158     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1461-3     Document Type: Article

References (24)

1. Kemp Z, Thirlwell C, Sieber O et al (2004) An update on the genetics of colorectal cancer. Hum Mol Genet 13:R177-R185
2. Slaby O, Svoboda M, Michalek J, Vyzula R (2009) MicroRNAs in colorectal cancer: Translation of molecular biology into clinical application. Mol Cancer 8:102
3. Chang KH, Miller N, Kheirelseid EA et al (2011) MicroRNA signature analysis in colorectal cancer: Identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 26(11):1415-1422
4. Hanahan D, Wienberg RA (2000) The hallmarks of cancer. Cell 100:57-70
5. Schetter AJ, Leung SY, Sohn JJ et al (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436
6. Slaby O, Svoboda M, Fabian P et al (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72:397-402
7. Zhang Z, Li Z, Gao C et al (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88:1358-1366
8. Yan LX, Wu QN, Zhang Y et al (2011) Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumro growth. Breast Cancer Res 13:R2
9. Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68:8164-8172
10. Selaru FM, Olaru AV, Kan T et al (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49:1595-1601
11. Wang ZX, Lu BB, Wang H et al (2011) MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 42:281-290
12. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328-14336
13. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L (2010) MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. doi:10.1007/s12032-010- 9563-7
14. Liu M, Tang Q, Qiu M et al (2011) miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 585:2998-3005
15. Torres A, Torres K, Paszkowski T et al (2011) Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: A preliminary report. Int J Gynecol Cancer 21:8-14
16. Lakomy R, Sana J, Hankeova S et al (2011) MiR-165, miR-196b, miR-181c, miR-21 expression levels and MGMT methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci. doi:10.1111/j.1349-7006. 2011.02092.x
17. Goswami RS, Waldron L, Machado J et al (2010) Optimization and analysis of quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffinembedded samples. BMC Biotechnol 10:47
18. Varkonyi-Gasic E, Hellens RP (2011) Quantitative stem-loop RTPCR for detection of microRNAs. Methods Mol Biol 744:145-157
19. Cho WC (2007) OncomiRs: The discovery and progress of micro-RNAs in cancers. Mol Cancer 6:60
20. Yan LX, Huang XF, Shao Q et al (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastases and patient poor prognosis. RNA 14:2348-2360
21. Valeri N, Gasparini P, Braconi C et al (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA mutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 107:21098-21103
22. Sayed D, He M, Hong C et al (2010) MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285:20281-20290
23. Zhou JY, Ma WL, Liang S et al (2009) Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells. BMB Rep 42:593-598
24. Liu M, Wu H, Liu T et al (2009) Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 19:828-837